Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Handen

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Cerebrovascular disease drives Alzheimer plasma biomarker concentrations in adults with Down syndromeNatalie C Edwards, Patrick J Lao, Mohamad J Alshikho, et al.
Acta Neuropathologica|March 22, 2026
Neuropathological measures of increased tau phosphorylation across the Down syndrome lifespanJesse R Pascual, Isabel Rivera, Halyma Nguyen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJulie K Wisch, Ziqiao Jiao, Patrick J Lao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2025
Longitudinal study of body mass index in relation to Alzheimer's disease pathology and symptomatology in Down syndromeVictoria L Fleming, Brian C Helsel, Lauren T Ptomey, et al.
The Lancet. Neurology|December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional studyAnna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
Annals of Neurology|September 22, 2025
Cross-Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's DiseaseOmar Abdelmoity, Julie K Wisch, James T Kennedy, et al.
The Lancet. Neurology|July 24, 2021
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional studyAnne M Fagan, Rachel L Henson, Yan Li, et al.
Brain : a Journal of Neurology|November 15, 2025
The tau biomarker cascade is condensed in Down syndrome compared to sporadic Alzheimer's diseaseMatthew D Zammit, Hailey Bruzzone, Karly A Cody, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 19, 2026
Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's diseaseJames T Kennedy, Julie K Wisch, Anna H Boerwinkle, et al.
The Lancet. Neurology|April 17, 2024
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional studyJulie K Wisch, Nicole S McKay, Anna H Boerwinkle, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Cerebrovascular disease drives Alzheimer plasma biomarker concentrations in adults with Down syndromeNatalie C Edwards, Patrick J Lao, Mohamad J Alshikho, et al.
Acta Neuropathologica|March 22, 2026
Neuropathological measures of increased tau phosphorylation across the Down syndrome lifespanJesse R Pascual, Isabel Rivera, Halyma Nguyen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJulie K Wisch, Ziqiao Jiao, Patrick J Lao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2025
Longitudinal study of body mass index in relation to Alzheimer's disease pathology and symptomatology in Down syndromeVictoria L Fleming, Brian C Helsel, Lauren T Ptomey, et al.
The Lancet. Neurology|December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional studyAnna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
Annals of Neurology|September 22, 2025
Cross-Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's DiseaseOmar Abdelmoity, Julie K Wisch, James T Kennedy, et al.
The Lancet. Neurology|July 24, 2021
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional studyAnne M Fagan, Rachel L Henson, Yan Li, et al.
Brain : a Journal of Neurology|November 15, 2025
The tau biomarker cascade is condensed in Down syndrome compared to sporadic Alzheimer's diseaseMatthew D Zammit, Hailey Bruzzone, Karly A Cody, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 19, 2026
Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's diseaseJames T Kennedy, Julie K Wisch, Anna H Boerwinkle, et al.
The Lancet. Neurology|April 17, 2024
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional studyJulie K Wisch, Nicole S McKay, Anna H Boerwinkle, et al.
Pageof 12